{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,19]],"date-time":"2026-06-19T02:22:16Z","timestamp":1781835736146,"version":"3.54.5"},"reference-count":56,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,8,4]],"date-time":"2025-08-04T00:00:00Z","timestamp":1754265600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,8,4]],"date-time":"2025-08-04T00:00:00Z","timestamp":1754265600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"the 2023 Fujian Medical University Sailing Fund Project"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Immunol Res"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1007\/s12026-025-09669-8","type":"journal-article","created":{"date-parts":[[2025,8,4]],"date-time":"2025-08-04T16:44:38Z","timestamp":1754325878000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["SOCS1 improves abnormal IgA galactosylation in IgA nephropathy by regulating the TLR9\/MyD88 pathway"],"prefix":"10.1007","volume":"73","author":[{"given":"Yanru","family":"Huang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qinghai","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunqin","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bingbing","family":"Qiu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shulian","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianxin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,8,4]]},"reference":[{"issue":"1","key":"9669_CR1","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1038\/s41581-024-00885-3","volume":"21","author":"CK Cheung","year":"2025","unstructured":"Cheung CK, Alexander S, Reich HN, Selvaskandan H, Zhang H, Barratt J. The pathogenesis of IgA nephropathy and implications for treatment. Nat Rev Nephrol. 2025;21(1):9\u201323. https:\/\/doi.org\/10.1038\/s41581-024-00885-3.","journal-title":"Nat Rev Nephrol"},{"key":"9669_CR2","doi-asserted-by":"publisher","unstructured":"Stamellou E, Seikrit C, Tang SCW, Boor P, Tesa\u0159 V, Floege J, et al. IgA nephropathy. Nat Rev Disease Primers. 2023;9(1):67. https:\/\/doi.org\/10.1038\/s41572-023-00476-9.","DOI":"10.1038\/s41572-023-00476-9"},{"key":"9669_CR3","doi-asserted-by":"publisher","unstructured":"Suzuki H, Novak J. Special issue: new insights into the pathogenesis and therapies of IgA nephropathy. J Clin Med. 2022;11(15). https:\/\/doi.org\/10.3390\/jcm11154378.","DOI":"10.3390\/jcm11154378"},{"issue":"10","key":"9669_CR4","doi-asserted-by":"publisher","first-page":"1624","DOI":"10.1093\/ndt\/gfae052","volume":"39","author":"Y Zhu","year":"2024","unstructured":"Zhu Y, He H, Sun W, Wu J, Xiao Y, Peng Y, et al. IgA nephropathy: gut microbiome regulates the production of hypoglycosilated IgA1 via the TLR4 signaling pathway. Nephrol, Dialysis, Transp\u202f: Off Publ Eur Dial Transplant Assoc - Eur Renal Assoc. 2024;39(10):1624\u201341. https:\/\/doi.org\/10.1093\/ndt\/gfae052.","journal-title":"Nephrol, Dialysis, Transp : Off Publ Eur Dial Transplant Assoc - Eur Renal Assoc"},{"issue":"5","key":"9669_CR5","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1038\/sj.ki.5002088","volume":"71","author":"GS Li","year":"2007","unstructured":"Li GS, Zhang H, Lv JC, Shen Y, Wang HY. Variants of C1GALT1 gene are associated with the genetic susceptibility to IgA nephropathy. Kidney Int. 2007;71(5):448\u201353. https:\/\/doi.org\/10.1038\/sj.ki.5002088.","journal-title":"Kidney Int"},{"issue":"5","key":"9669_CR6","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1016\/j.semnephrol.2018.05.016","volume":"38","author":"J Novak","year":"2018","unstructured":"Novak J, Barratt J, Julian BA, Renfrow MB. Aberrant glycosylation of the IgA1 molecule in IgA nephropathy. Semin Nephrol. 2018;38(5):461\u201376. https:\/\/doi.org\/10.1016\/j.semnephrol.2018.05.016.","journal-title":"Semin Nephrol"},{"key":"9669_CR7","doi-asserted-by":"publisher","first-page":"1419951","DOI":"10.3389\/fimmu.2024.1419951","volume":"15","author":"GM Bidgood","year":"2024","unstructured":"Bidgood GM, Keating N, Doggett K, Nicholson SE. SOCS1 is a critical checkpoint in immune homeostasis, inflammation and tumor immunity. Front Immunol. 2024;15:1419951. https:\/\/doi.org\/10.3389\/fimmu.2024.1419951.","journal-title":"Front Immunol"},{"issue":"15","key":"9669_CR8","doi-asserted-by":"publisher","first-page":"3802","DOI":"10.1111\/febs.16780","volume":"290","author":"KC Lockwood","year":"2023","unstructured":"Lockwood KC, Lear TB, Rajbhandari S, McKelvey AC, Dunn SR, Boudreau \u00c1N, et al. KIAA0317 regulates SOCS1 stability to ameliorate colonic inflammation. FEBS J. 2023;290(15):3802\u201311. https:\/\/doi.org\/10.1111\/febs.16780.","journal-title":"FEBS J"},{"issue":"9","key":"9669_CR9","doi-asserted-by":"publisher","first-page":"1971","DOI":"10.1002\/ijc.27318","volume":"130","author":"J Zhang","year":"2012","unstructured":"Zhang J, Li H, Yu JP, Wang SE, Ren XB. Role of SOCS1 in tumor progression and therapeutic application. Int J Cancer. 2012;130(9):1971\u201380. https:\/\/doi.org\/10.1002\/ijc.27318.","journal-title":"Int J Cancer"},{"key":"9669_CR10","doi-asserted-by":"publisher","first-page":"155418","DOI":"10.1016\/j.cyto.2020.155418","volume":"140","author":"T Sheikh","year":"2021","unstructured":"Sheikh T, Sen E. p53 affects epigenetic signature on SOCS1 promoter in response to TLR4 inhibition. Cytokine. 2021;140:155418. https:\/\/doi.org\/10.1016\/j.cyto.2020.155418.","journal-title":"Cytokine"},{"issue":"Suppl 2","key":"9669_CR11","doi-asserted-by":"publisher","first-page":"S61","DOI":"10.1016\/s0264-410x(03)00202-0","volume":"21","author":"K Heeg","year":"2003","unstructured":"Heeg K, Dalpke A. TLR-induced negative regulatory circuits: role of suppressor of cytokine signaling (SOCS) proteins in innate immunity. Vaccine. 2003;21(Suppl 2):S61\u20137. https:\/\/doi.org\/10.1016\/s0264-410x(03)00202-0.","journal-title":"Vaccine"},{"issue":"12","key":"9669_CR12","doi-asserted-by":"publisher","first-page":"4024","DOI":"10.4049\/jimmunol.1700510","volume":"200","author":"CF Yu","year":"2018","unstructured":"Yu CF, Peng WM, Schlee M, Barchet W, Eis-H\u00fcbinger AM, Kolanus W, et al. SOCS1 and SOCS3 target IRF7 degradation to suppress TLR7-mediated type I IFN production of human plasmacytoid dendritic cells. J Immunol (Baltimore, Md: 1950). 2018;200(12):4024\u201335. https:\/\/doi.org\/10.4049\/jimmunol.1700510.","journal-title":"J Immunol (Baltimore, Md.: 1950)"},{"issue":"2","key":"9669_CR13","doi-asserted-by":"publisher","first-page":"112","DOI":"10.3892\/etm.2020.9544","volume":"21","author":"H Liu","year":"2021","unstructured":"Liu H, Wang W, Liu C. Increased expression of IFN-\u03b3 in preeclampsia impairs human trophoblast invasion via a SOCS1\/JAK\/STAT1 feedback loop. Exp Ther Med. 2021;21(2):112. https:\/\/doi.org\/10.3892\/etm.2020.9544.","journal-title":"Exp Ther Med"},{"issue":"2","key":"9669_CR14","doi-asserted-by":"publisher","first-page":"237","DOI":"10.15283\/ijsc20001","volume":"13","author":"L Zhang","year":"2020","unstructured":"Zhang L, Qu YN, Zhang HY, Wu ZY, Li ZL, Guo WB, et al. SOCS1 regulates the immunomodulatory roles of MSCs on B cells. Int J Stem Cells. 2020;13(2):237\u201345. https:\/\/doi.org\/10.15283\/ijsc20001.","journal-title":"Int J Stem Cells"},{"issue":"3","key":"9669_CR15","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1007\/s10238-014-0309-2","volume":"15","author":"LJ Qiu","year":"2015","unstructured":"Qiu LJ, Xu K, Liang Y, Cen H, Zhang M, Wen PF, et al. Decreased SOCS1 mRNA expression levels in peripheral blood mononuclear cells from patients with systemic lupus erythematosus in a Chinese population. Clin Exp Med. 2015;15(3):261\u20137. https:\/\/doi.org\/10.1007\/s10238-014-0309-2.","journal-title":"Clin Exp Med"},{"key":"9669_CR16","doi-asserted-by":"publisher","first-page":"102883","DOI":"10.1016\/j.jaut.2022.102883","volume":"132","author":"C Reily","year":"2022","unstructured":"Reily C, Rice T, Crossman DK, Rizk DV. Phosphatase control of cytokine-mediated overproduction of galactose-deficient IgA1, the main autoantigen in IgA nephropathy. J Autoimmun. 2022;132:102883. https:\/\/doi.org\/10.1016\/j.jaut.2022.102883.","journal-title":"J Autoimmun"},{"key":"9669_CR17","doi-asserted-by":"publisher","first-page":"461","DOI":"10.3389\/fimmu.2014.00461","volume":"5","author":"T Kawasaki","year":"2014","unstructured":"Kawasaki T, Kawai T. Toll-like receptor signaling pathways. Front Immunol. 2014;5:461. https:\/\/doi.org\/10.3389\/fimmu.2014.00461.","journal-title":"Front Immunol"},{"key":"9669_CR18","doi-asserted-by":"publisher","unstructured":"\u00c7akan E, Ah Kioon MD, Garcia-Carmona Y, Glauzy S, Oliver D, Yamakawa N, et al. TLR9 ligand sequestration by chemokine CXCL4 negatively affects central B cell tolerance. J Exp Med. 2023;220(12). https:\/\/doi.org\/10.1084\/jem.20230944.","DOI":"10.1084\/jem.20230944"},{"issue":"3","key":"9669_CR19","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/j.it.2023.01.008","volume":"44","author":"S Zhang","year":"2023","unstructured":"Zhang S, Cao X. TLR9 triggers MyD88-independent anti-inflammatory signaling in lupus. Trends Immunol. 2023;44(3):153\u20135. https:\/\/doi.org\/10.1016\/j.it.2023.01.008.","journal-title":"Trends Immunol"},{"issue":"6","key":"9669_CR20","doi-asserted-by":"publisher","first-page":"1251","DOI":"10.1007\/s40620-020-00722-3","volume":"33","author":"J Zhang","year":"2020","unstructured":"Zhang J, Mi Y, Zhou R, Liu Z, Huang B, Guo R, et al. The TLR4-MyD88-NF-\u03baB pathway is involved in sIgA-mediated IgA nephropathy. J Nephrol. 2020;33(6):1251\u201361. https:\/\/doi.org\/10.1007\/s40620-020-00722-3.","journal-title":"J Nephrol"},{"issue":"12","key":"9669_CR21","doi-asserted-by":"publisher","first-page":"2384","DOI":"10.1681\/asn.2007121311","volume":"19","author":"H Suzuki","year":"2008","unstructured":"Suzuki H, Suzuki Y, Narita I, Aizawa M, Kihara M, Yamanaka T, et al. Toll-like receptor 9 affects severity of IgA nephropathy. J Am Soc Nephrol. 2008;19(12):2384\u201395. https:\/\/doi.org\/10.1681\/asn.2007121311.","journal-title":"J Am Soc Nephrol"},{"issue":"2","key":"9669_CR22","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1016\/j.kint.2019.08.022","volume":"97","author":"Y Makita","year":"2020","unstructured":"Makita Y, Suzuki H, Kano T, Takahata A, Julian BA, Novak J, et al. TLR9 activation induces aberrant IgA glycosylation via APRIL- and IL-6-mediated pathways in IgA nephropathy. Kidney Int. 2020;97(2):340\u20139. https:\/\/doi.org\/10.1016\/j.kint.2019.08.022.","journal-title":"Kidney Int"},{"key":"9669_CR23","doi-asserted-by":"publisher","first-page":"563699","DOI":"10.3389\/fimmu.2020.563699","volume":"11","author":"C Liu","year":"2020","unstructured":"Liu C, Ye MY, Yan WZ, Peng XF, He LY, Peng YM. MicroRNA-630 regulates underglycosylated IgA1 production in the tonsils by targeting TLR4 in IgA nephropathy. Front Immunol. 2020;11:563699. https:\/\/doi.org\/10.3389\/fimmu.2020.563699.","journal-title":"Front Immunol"},{"key":"9669_CR24","doi-asserted-by":"publisher","first-page":"658236","DOI":"10.3389\/fphar.2021.658236","volume":"12","author":"C Liu","year":"2021","unstructured":"Liu C, Li X, Shuai L, Dang X, Peng F, Zhao M, et al. Astragaloside IV inhibits galactose-deficient IgA1 secretion via miR-98-5p in pediatric IgA nephropathy. Front Pharmacol. 2021;12:658236. https:\/\/doi.org\/10.3389\/fphar.2021.658236.","journal-title":"Front Pharmacol"},{"issue":"2","key":"9669_CR25","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1111\/j.1523-1755.2005.67107.x","volume":"67","author":"J Novak","year":"2005","unstructured":"Novak J, Tomana M, Matousovic K, Brown R, Hall S, Novak L, et al. IgA1-containing immune complexes in IgA nephropathy differentially affect proliferation of mesangial cells. Kidney Int. 2005;67(2):504\u201313. https:\/\/doi.org\/10.1111\/j.1523-1755.2005.67107.x.","journal-title":"Kidney Int"},{"issue":"10","key":"9669_CR26","doi-asserted-by":"publisher","first-page":"1795","DOI":"10.1681\/asn.2011050464","volume":"22","author":"H Suzuki","year":"2011","unstructured":"Suzuki H, Kiryluk K, Novak J, Moldoveanu Z, Herr AB, Renfrow MB, et al. The pathophysiology of IgA nephropathy. J Am Soc Nephrol. 2011;22(10):1795\u2013803. https:\/\/doi.org\/10.1681\/asn.2011050464.","journal-title":"J Am Soc Nephrol"},{"issue":"5","key":"9669_CR27","doi-asserted-by":"publisher","first-page":"814","DOI":"10.1681\/asn.2011060567","volume":"23","author":"G Serino","year":"2012","unstructured":"Serino G, Sallustio F, Cox SN, Pesce F, Schena FP. Abnormal miR-148b expression promotes aberrant glycosylation of IgA1 in IgA nephropathy. J Am Soc Nephrol. 2012;23(5):814\u201324. https:\/\/doi.org\/10.1681\/asn.2011060567.","journal-title":"J Am Soc Nephrol"},{"issue":"D1","key":"9669_CR28","doi-asserted-by":"publisher","first-page":"D138","DOI":"10.1093\/nar\/gkad965","volume":"52","author":"E Clough","year":"2024","unstructured":"Clough E, Barrett T, Wilhite SE, Ledoux P, Evangelista C, Kim IF, et al. NCBI GEO: archive for gene expression and epigenomics data sets: 23-year update. Nucleic Acids Res. 2024;52(D1):D138\u201344. https:\/\/doi.org\/10.1093\/nar\/gkad965.","journal-title":"Nucleic Acids Res"},{"key":"9669_CR29","doi-asserted-by":"publisher","first-page":"1679","DOI":"10.2147\/dddt.s403422","volume":"17","author":"WG Yang","year":"2023","unstructured":"Yang WG, Sun A, Zhu R, Liu N, He WJ, Liu LL. Exploration of artemisinin against IgA nephropathy via AKT\/Nrf2 pathway by bioinformatics and experimental validation. Drug Des Dev Ther. 2023;17:1679\u201397. https:\/\/doi.org\/10.2147\/dddt.s403422.","journal-title":"Drug Des Dev Ther"},{"issue":"9","key":"9669_CR30","doi-asserted-by":"publisher","first-page":"e13278","DOI":"10.1111\/cpr.13278","volume":"55","author":"L Zhao","year":"2022","unstructured":"Zhao L, Lan Z, Peng L, Wan L, Liu D, Tan X, et al. Triptolide promotes autophagy to inhibit mesangial cell proliferation in IgA nephropathy via the CARD9\/p38 MAPK pathway. Cell Prolif. 2022;55(9):e13278. https:\/\/doi.org\/10.1111\/cpr.13278.","journal-title":"Cell Prolif"},{"issue":"13","key":"9669_CR31","doi-asserted-by":"publisher","first-page":"3343","DOI":"10.7150\/ijbs.61274","volume":"17","author":"Y Li","year":"2021","unstructured":"Li Y, Xia M, Peng L, Liu H, Chen G, Wang C, et al. Downregulation of miR-214-3p attenuates mesangial hypercellularity by targeting PTEN-mediated JNK\/c-Jun signaling in IgA nephropathy. Int J Biol Sci. 2021;17(13):3343\u201355. https:\/\/doi.org\/10.7150\/ijbs.61274.","journal-title":"Int J Biol Sci"},{"issue":"5","key":"9669_CR32","doi-asserted-by":"publisher","first-page":"763","DOI":"10.1681\/asn.2009060625","volume":"21","author":"G Ortiz-Mu\u00f1oz","year":"2010","unstructured":"Ortiz-Mu\u00f1oz G, Lopez-Parra V, Lopez-Franco O, Fernandez-Vizarra P, Mallavia B, Flores C, et al. Suppressors of cytokine signaling abrogate diabetic nephropathy. J Am Soc Nephrol. 2010;21(5):763\u201372. https:\/\/doi.org\/10.1681\/asn.2009060625.","journal-title":"J Am Soc Nephrol"},{"key":"9669_CR33","doi-asserted-by":"publisher","first-page":"102041","DOI":"10.1016\/j.omtn.2023.102041","volume":"34","author":"I Prieto","year":"2023","unstructured":"Prieto I, Kavanagh M, Jimenez-Castilla L, Pardines M, Lazaro I, Herrero Del Real I, et al. A mutual regulatory loop between miR-155 and SOCS1 influences renal inflammation and diabetic kidney disease. Mol Ther Nucleic Acids. 2023;34:102041. https:\/\/doi.org\/10.1016\/j.omtn.2023.102041.","journal-title":"Mol Ther Nucleic Acids"},{"issue":"6","key":"9669_CR34","doi-asserted-by":"publisher","first-page":"e942","DOI":"10.1002\/ctm2.942","volume":"12","author":"Q Sun","year":"2022","unstructured":"Sun Q, Geng H, Zhao M, Li Y, Chen X, Sha Q, et al. FTO-mediated m(6) A modification of SOCS1 mRNA promotes the progression of diabetic kidney disease. Clin Transl Med. 2022;12(6):e942. https:\/\/doi.org\/10.1002\/ctm2.942.","journal-title":"Clin Transl Med"},{"key":"9669_CR35","doi-asserted-by":"publisher","first-page":"118855","DOI":"10.1016\/j.lfs.2020.118855","volume":"265","author":"M Zhu","year":"2021","unstructured":"Zhu M, Wang H, Chen J, Zhu H. Sinomenine improve diabetic nephropathy by inhibiting fibrosis and regulating the JAK2\/STAT3\/SOCS1 pathway in streptozotocin-induced diabetic rats. Life Sci. 2021;265:118855. https:\/\/doi.org\/10.1016\/j.lfs.2020.118855.","journal-title":"Life Sci"},{"issue":"10","key":"9669_CR36","doi-asserted-by":"publisher","first-page":"1276","DOI":"10.1038\/s41374-018-0043-6","volume":"98","author":"L Lopez-Sanz","year":"2018","unstructured":"Lopez-Sanz L, Bernal S, Recio C, Lazaro I, Oguiza A, Melgar A, et al. SOCS1-targeted therapy ameliorates renal and vascular oxidative stress in diabetes via STAT1 and PI3K inhibition. Lab Invest; J Tech Methods Pathol. 2018;98(10):1276\u201390. https:\/\/doi.org\/10.1038\/s41374-018-0043-6.","journal-title":"Lab Invest; J Tech Methods Pathol"},{"issue":"7","key":"9669_CR37","doi-asserted-by":"publisher","first-page":"1073","DOI":"10.1681\/asn.2012080849","volume":"24","author":"H Zhou","year":"2013","unstructured":"Zhou H, Hasni SA, Perez P, Tandon M, Jang SI, Zheng C, et al. miR-150 promotes renal fibrosis in lupus nephritis by downregulating SOCS1. J Am Soc Nephrol. 2013;24(7):1073\u201387. https:\/\/doi.org\/10.1681\/asn.2012080849.","journal-title":"J Am Soc Nephrol"},{"key":"9669_CR38","doi-asserted-by":"publisher","first-page":"1292","DOI":"10.3389\/fimmu.2017.01292","volume":"8","author":"H Wang","year":"2017","unstructured":"Wang H, Wang J, Xia Y. Defective suppressor of cytokine signaling 1 signaling contributes to the pathogenesis of systemic lupus erythematosus. Front Immunol. 2017;8:1292. https:\/\/doi.org\/10.3389\/fimmu.2017.01292.","journal-title":"Front Immunol"},{"issue":"2","key":"9669_CR39","doi-asserted-by":"publisher","first-page":"943","DOI":"10.1073\/pnas.022628499","volume":"99","author":"D Metcalf","year":"2002","unstructured":"Metcalf D, Mifsud S, Di Rago L, Nicola NA, Hilton DJ, Alexander WS. Polycystic kidneys and chronic inflammatory lesions are the delayed consequences of loss of the suppressor of cytokine signaling-1 (SOCS-1). Proc Natl Acad Sci U S A. 2002;99(2):943\u20138. https:\/\/doi.org\/10.1073\/pnas.022628499.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"9669_CR40","doi-asserted-by":"publisher","first-page":"610","DOI":"10.3389\/fimmu.2017.00610","volume":"8","author":"P Wang","year":"2017","unstructured":"Wang P, Yang J, Tong F, Duan Z, Liu X, Xia L, et al. Anti-double-stranded DNA IgG participates in renal fibrosis through suppressing the suppressor of cytokine signaling 1 signals. Front Immunol. 2017;8:610. https:\/\/doi.org\/10.3389\/fimmu.2017.00610.","journal-title":"Front Immunol"},{"issue":"1","key":"9669_CR41","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1038\/s41418-019-0349-y","volume":"27","author":"LL Lv","year":"2020","unstructured":"Lv LL, Feng Y, Wu M, Wang B, Li ZL, Zhong X, et al. Exosomal miRNA-19b-3p of tubular epithelial cells promotes M1 macrophage activation in kidney injury. Cell Death Differ. 2020;27(1):210\u201326. https:\/\/doi.org\/10.1038\/s41418-019-0349-y.","journal-title":"Cell Death Differ"},{"issue":"6","key":"9669_CR42","doi-asserted-by":"publisher","first-page":"2402","DOI":"10.1007\/s10753-023-01886-3","volume":"46","author":"Y Zhao","year":"2023","unstructured":"Zhao Y, Peng F, He J, Qu Y, Ni H, Wu L, et al. SOCS1 peptidomimetic alleviates glomerular inflammation in MsPGN by inhibiting macrophage M1 polarization. Inflammation. 2023;46(6):2402\u201314. https:\/\/doi.org\/10.1007\/s10753-023-01886-3.","journal-title":"Inflammation"},{"issue":"3","key":"9669_CR43","doi-asserted-by":"publisher","first-page":"1469","DOI":"10.3892\/mmr.2014.2359","volume":"10","author":"W Li","year":"2014","unstructured":"Li W, Peng X, Liu Y, Liu H, Liu F, He L, et al. TLR9 and BAFF: their expression in patients with IgA nephropathy. Mol Med Rep. 2014;10(3):1469\u201374. https:\/\/doi.org\/10.3892\/mmr.2014.2359.","journal-title":"Mol Med Rep"},{"issue":"3","key":"9669_CR44","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1620\/tjem.240.199","volume":"240","author":"A Saito","year":"2016","unstructured":"Saito A, Komatsuda A, Kaga H, Sato R, Togashi M, Okuyama S, et al. Different expression patterns of toll-like receptor mRNAs in blood mononuclear cells of IgA nephropathy and IgA vasculitis with nephritis. Tohoku J Exp Med. 2016;240(3):199\u2013208. https:\/\/doi.org\/10.1620\/tjem.240.199.","journal-title":"Tohoku J Exp Med"},{"issue":"4","key":"9669_CR45","doi-asserted-by":"publisher","first-page":"1227","DOI":"10.1681\/asn.2016050496","volume":"28","author":"M Muto","year":"2017","unstructured":"Muto M, Manfroi B, Suzuki H, Joh K, Nagai M, Wakai S, et al. Toll-like receptor 9 stimulation induces aberrant expression of a proliferation-inducing ligand by tonsillar germinal center B cells in IgA nephropathy. J Am Soc Nephrol. 2017;28(4):1227\u201338. https:\/\/doi.org\/10.1681\/asn.2016050496.","journal-title":"J Am Soc Nephrol"},{"key":"9669_CR46","doi-asserted-by":"publisher","unstructured":"Suzuki H, Novak J. IgA nephropathy: significance of IgA1-containing immune complexes in clinical settings. Journal of clinical medicine. 2024;13(15). https:\/\/doi.org\/10.3390\/jcm13154495.","DOI":"10.3390\/jcm13154495"},{"issue":"2","key":"9669_CR47","doi-asserted-by":"publisher","first-page":"774","DOI":"10.1021\/acsabm.2c00963","volume":"6","author":"K Sumiya","year":"2023","unstructured":"Sumiya K, Izumi H, Sakurai K. Enhanced therapeutic efficacy of immunostimulatory CpG-ODN by silencing SOCS-1 with polysaccharide\/miR-155 complexes. ACS Appl Bio Mater. 2023;6(2):774\u201383. https:\/\/doi.org\/10.1021\/acsabm.2c00963.","journal-title":"ACS Appl Bio Mater"},{"key":"9669_CR48","doi-asserted-by":"publisher","unstructured":"Fujimoto M, Naka T. SOCS1, a negative regulator of cytokine signals and TLR responses, in human liver diseases. Gastroenterology research and practice. 2010;2010. https:\/\/doi.org\/10.1155\/2010\/470468.","DOI":"10.1155\/2010\/470468"},{"issue":"11","key":"9669_CR49","doi-asserted-by":"publisher","first-page":"5644","DOI":"10.4049\/jimmunol.1103068","volume":"188","author":"ME Eberle","year":"2012","unstructured":"Eberle ME, Dalpke AH. Dectin-1 stimulation induces suppressor of cytokine signaling 1, thereby modulating TLR signaling and T cell responses. J Immunol (Baltimore, Md\u202f: 1950). 2012;188(11):5644\u201354. https:\/\/doi.org\/10.4049\/jimmunol.1103068.","journal-title":"J Immunol (Baltimore, Md : 1950)."},{"issue":"20","key":"9669_CR50","doi-asserted-by":"publisher","first-page":"9228","DOI":"10.1073\/pnas.0914004107","volume":"107","author":"Y Wang","year":"2010","unstructured":"Wang Y, Ju T, Ding X, Xia B, Wang W, Xia L, et al. Cosmc is an essential chaperone for correct protein O-glycosylation. Proc Natl Acad Sci USA. 2010;107(20):9228\u201333. https:\/\/doi.org\/10.1073\/pnas.0914004107.","journal-title":"Proc Natl Acad Sci USA"},{"issue":"3","key":"9669_CR51","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1083\/jcb.200311112","volume":"164","author":"L Xia","year":"2004","unstructured":"Xia L, Ju T, Westmuckett A, An G, Ivanciu L, McDaniel JM, et al. Defective angiogenesis and fatal embryonic hemorrhage in mice lacking core 1-derived O-glycans. J Cell Biol. 2004;164(3):451\u20139. https:\/\/doi.org\/10.1083\/jcb.200311112.","journal-title":"J Cell Biol"},{"issue":"2","key":"9669_CR52","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1080\/08923973.2023.2300306","volume":"46","author":"C Wang","year":"2024","unstructured":"Wang C, Cai X, Lin S, Lin Y. Hydroxychloroquine ameliorates immune functionality and intestinal flora disorders of IgA nephropathy by inhibition of C1GALT1\/Cosmc pathway. Immunopharmacol Immunotoxicol. 2024;46(2):218\u201328. https:\/\/doi.org\/10.1080\/08923973.2023.2300306.","journal-title":"Immunopharmacol Immunotoxicol"},{"issue":"44","key":"9669_CR53","doi-asserted-by":"publisher","first-page":"16442","DOI":"10.1073\/pnas.0607872103","volume":"103","author":"WS Alexander","year":"2006","unstructured":"Alexander WS, Viney EM, Zhang JG, Metcalf D, Kauppi M, Hyland CD, et al. Thrombocytopenia and kidney disease in mice with a mutation in the C1galt1 gene. Proc Natl Acad Sci USA. 2006;103(44):16442\u20137. https:\/\/doi.org\/10.1073\/pnas.0607872103.","journal-title":"Proc Natl Acad Sci USA"},{"issue":"8","key":"9669_CR54","doi-asserted-by":"publisher","first-page":"5330","DOI":"10.1074\/jbc.M113.512277","volume":"289","author":"H Suzuki","year":"2014","unstructured":"Suzuki H, Raska M, Yamada K, Moldoveanu Z, Julian BA, Wyatt RJ, et al. Cytokines alter IgA1 O-glycosylation by dysregulating C1GalT1 and ST6GalNAc-II enzymes. J Biol Chem. 2014;289(8):5330\u20139. https:\/\/doi.org\/10.1074\/jbc.M113.512277.","journal-title":"J Biol Chem"},{"key":"9669_CR55","doi-asserted-by":"publisher","unstructured":"Prakash S, Steers NJ, Li Y, Sanchez-Rodriguez E, Verbitsky M, Robbins I, et al. Loss of GalNAc-T14 links O-glycosylation defects to alterations in B cell homing in IgA nephropathy. J Clin Investig. 2025;135(10). https:\/\/doi.org\/10.1172\/jci181164.","DOI":"10.1172\/jci181164"},{"issue":"2","key":"9669_CR56","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1007\/s12016-010-8232-0","volume":"41","author":"HH Yu","year":"2011","unstructured":"Yu HH, Chu KH, Yang YH, Lee JH, Wang LC, Lin YT, et al. Genetics and immunopathogenesis of IgA nephropathy. Clin Rev Allergy Immunol. 2011;41(2):198\u2013213. https:\/\/doi.org\/10.1007\/s12016-010-8232-0.","journal-title":"Clin Rev Allergy Immunol"}],"container-title":["Immunologic Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12026-025-09669-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12026-025-09669-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12026-025-09669-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,4]],"date-time":"2026-02-04T07:29:30Z","timestamp":1770190170000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12026-025-09669-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,4]]},"references-count":56,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["9669"],"URL":"https:\/\/doi.org\/10.1007\/s12026-025-09669-8","relation":{},"ISSN":["0257-277X","1559-0755"],"issn-type":[{"value":"0257-277X","type":"print"},{"value":"1559-0755","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,4]]},"assertion":[{"value":"30 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 July 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 August 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The study was reviewed by the Ethics Committee of Quanzhou First Hospital Affiliated to Fujian Medical University, and all subjects voluntarily agreed to participate in the study and signed an informed consent form. All animal studies were approved and supervised by the Laboratory Animal Care and Use Committee of Quanzhou First Hospital Affiliated to Fujian Medical University. All methods were carried out in accordance with relevant guidelines and regulations. This study was carried out in compliance with the ARRIVE guidelines.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}],"article-number":"115"}}